Dr. Stein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
676 N St Clair St
Chicago, IL 60611
Education & Training
University of MichiganLaryngology fellow, 2020 - 2021
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Otolaryngology - Head and Neck Surgery, 2015 - 2020
University of Wisconsin School of Medicine & Public HealthClass of 2015- Washington University in St. LouisBS, Biochemistry, 2006 - 2010
Certifications & Licensure
IL State Medical License 2021 - 2026
MI State Medical License 2020 - 2023
OH State Medical License 2015 - 2021- American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Publications & Presentations
PubMed
- 150 citationsAXL Mediates Resistance to Cetuximab TherapyToni M. Brand, Mari Iida, Andrew P. Stein, Kelsey L. Corrigan, Cara M. Braverman
Cancer Research. 2014-09-15 - 22 citationsAnti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma.Nathan J. Redlich, Anthony M. Robinson, Kwangok P. Nickel, Andrew P. Stein, Deric L. Wheeler
Cell Death & Disease. 2018-01-05 - 84 citationsAXL Is a Logical Molecular Target in Head and Neck Squamous Cell CarcinomaToni M. Brand, Mari Iida, Andrew P. Stein, Kelsey L. Corrigan, Cara M. Braverman
Clinical Cancer Research. 2015-03-12
Journal Articles
- A Destructive Sinonasal Process Leading to Sudden BlindnessAndrew Stein, MD, JAMA
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
